HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tylenol Leads OTC Acetaminophen Sales Surge After Ibuprofen Scare During Pandemic – IRI

Executive Summary

J&J leads sales growth in OTC pain relief and allergy categories in 2020 as its brands benefited from competing products’ problems and COVID-19’s impact of consumer habits. IRI reveals winning brands that kept a focus on maintaining health in 2020.

You may also be interested in...



Studies On Treating COVID-19 Inflammation And Migraines Also Weigh Efficacy Of Remote Trials

Preliminary data from Cold Springs Harbor Laboratory study suggest famotidine could mitigate inflammatory symptoms of COVID-19 in adults. Research sponsored by Nestle Health Science in Canada also points to remote studies likely to continue after emerging as a pandemic innovation.

With Spring's Arrival, OTC Allergy Ad Campaigns Bloom In US For Claritin, Flonase

Bayer launches multi-year campaign “Outsideologist Project” for Claritin to offer parents fun ways to get their children outside. GSK’s “Change the Game” campaign for Flonase as official allergy relief partner of MLB has new spokesman.

J&J’s Consumer Health Product Sales Slump In Comparison A Year After COVID-19 Stockpiling

Worldwide consumer health sales in January-March period were down 3.3% to $3.5bn with results off 7.4% to $1.6bn in the US and up 0.5% to $1.9bn internationally. However, excluding “COVID-19 comparison” in the year-ago period, the consumer health segment grew low-single-digits.

Related Content

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

RS151229

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel